help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 16, 2006, doi:10.1165/rcmb.2005-0293OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0293OCv1
35/2/211    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koch, M.
Right arrow Articles by Kaufmann, S. H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, M.
Right arrow Articles by Kaufmann, S. H. E.
American Journal of Respiratory Cell and Molecular Biology. Vol. 35, pp. 211-219, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0293OC

Role of Local Pulmonary IFN-{gamma} Expression in Murine Allergic Airway Inflammation

Markus Koch, Martin Witzenrath, Christine Reuter, Marion Herma, Hartwig Schütte, Norbert Suttorp, Helen Collins and Stefan H. E. Kaufmann

Department of Immunology, Max-Planck-Institute for Infection Biology, Berlin; Department of Internal Medicine, Charite, Humboldt-University, Berlin, Germany; and Division of Life Sciences, Kings College London, London, United Kingdom

Correspondence and requests for reprints should be addressed to Markus Koch, Department of Immunology, Max-Planck-Institute for Infection Biology, Campus Charité Mitte, Schumannstrasse 21/22, 10117 Berlin, Germany. E-mail: koch{at}mpiib-berlin.mpg.de

Generalized underrepresentation of IFN-{gamma} has been implicated in the development of allergic asthma. However, the role of local IFN-{gamma} in the lung during the development of this disease has not been completely elucidated. We studied the influence of local pulmonary IFN-{gamma} expression on the development of allergen-induced lung inflammation. To restrict our analysis to IFN-{gamma} expression in the lung and to exclude influences of systemic IFN-{gamma} production, we generated a transgenic mouse line with a targeted deletion of the IFN-{gamma} gene and constitutive, lung-specific IFN-{gamma} expression (Clara cell 10 [CC10]–IFN-{gamma}–tg–IFN-{gamma}–KO mice), and compared allergen-induced airway inflammation in these mice with that of wild-type and IFN-{gamma}– KO mice on the C57BL/6 background. Cytokine quantification in lungs of mice with allergic airway inflammation revealed that pulmonary IFN-{gamma} expression increased expression of IL-5 and IL-13. Consistent with this observation, eosinophilia in bronchoalveolar lavage of CC10–IFN-{gamma}–tg–IFN-{gamma}–KO mice was profoundly increased, indicating that this critical component of asthma is enhanced by local IFN-{gamma} expression. In contrast, airway hyperresponsiveness and anti-ovalbumin-IgE serum levels were reduced by local IFN-{gamma} expression. Together, our results demonstrate pleiotropic action of constitutive IFN-{gamma} expression in the lung, and question the therapeutic value of IFN-{gamma} in allergic asthma. Local expression of IFN-{gamma} in the lung increases markers of allergic airway inflammation, but decreases airway hyperresponsiveness in a murine model of allergic-asthma

Key Words: airway hyperresponsiveness • asthma • eosinophilia • IFN-{gamma} • transgenic mice




This article has been cited by other articles:


Home page
Eur Respir JHome page
Y. Suzaki, K. Hamada, T. Nomi, T. Ito, M. Sho, Y. Kai, Y. Nakajima, and H. Kimura
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation
Eur. Respir. J., April 1, 2008; 31(4): 783 - 789.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
O. Tliba and Y. Amrani
Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways
Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. Xu, K. Aoyama, M. Kusumoto, A. Matsuzawa, E. C. Butcher, S. A. Michie, T. Matsuyama, and T. Takeuchi
Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice
Int. Immunol., June 1, 2007; 19(6): 775 - 784.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Meyts, P. W. Hellings, G. Hens, B. M. Vanaudenaerde, B. Verbinnen, H. Heremans, P. Matthys, D. M. Bullens, L. Overbergh, C. Mathieu, et al.
IL-12 Contributes to Allergen-Induced Airway Inflammation in Experimental Asthma
J. Immunol., November 1, 2006; 177(9): 6460 - 6470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.